Serena Lang-Moreira

• Delivered consistent +3-4% YoY revenue growth while leading commercialization and growth strategy for an approximately $80M global infusion portfolio .
• Protected $10M of China business exposure by developing a commercial response to Volume-Based Procurement and aligning global and local stakeholders.
• Expanded OPAT therapy in Western Europe, Colombia and Malaysia through KOL engagement and collaboration with Medical and Market Access teams achieving 6% revenue growth.
• Delivered five successful Elastomeric launches in Brazil, Hong Kong, Qatar, Kuwait and the UAE, accelerating geographic expansion .
• Strengthened long-term portfolio competitiveness through two strategic partnership management, Voice of Customer insights, forecasting and cost-reduction initiatives.

• Drove up to +6% business growth across the Medication Delivery portfolio by translating global strategy into market-specific commercial priorities across ECEMEA.
• Enabled Gulf market expansion by leading the end-to-end IV fluids program from R&D development and regulatory approval through commercial launch, successfully bringing 10+ small- and large-volume IV infusion bags to market; recognized by Baxter CEO Joe Almeida with the “Cup of Joe” award.
• Delivered 15+ product launches across IV drugs/fluids, infusion systems, diagnostics, software and access products, expanding the regional portfolio footprint.
• Improved profitability by 5% and operational efficiency through regional SKU rationalization, portfolio synergies and commercial prioritization .
• Integrated Cheetah Medical into Baxter ECEMEA operations and served as commercial lead for the local commercial strategy.
• Executed multiple market analysis across EMEA to inform strategy by assessing trends, monitoring competitor activities, and evaluating customer behavior and preferences from in-field activities .
• Developed and executed regional marketing strategies to enhance brand awareness and drive market penetration .
• Collaborated with cross-functional teams to align marketing initiatives with corporate objectives and sales goals.

• Expanded responsibility to the full ECEMEA Medication Delivery portfolio, enabling broader regional commercialization across diverse healthcare markets.
• Supported 5 geographic expansion and product introduction by aligning portfolio priorities with local market needs, infrastructure and customer requirements .
• Strengthened commercial decision-making through market , competitor and customer analysis across Eastern/Central Europe, Middle East and Africa.

• Advanced commercialization of the EVOIQ infusion platform and DOSEIQ safety software across Middle East and Africa through commercial and digital strategy .
• Identified market expansion and launch opportunities through analysis of market size, reimbursement , purchasing policies, competition and customer needs.
• Improved regional alignment and commercial execution by partnering with ECEMEA General Managers, Commercial Excellence and global/regional stakeholders .

• Supported compliant business operations by helping ensure adherence to Swiss and EU legal and compliance requirements.
• Worked effectively in fast-paced environments.
• Skilled at working independently and collaboratively in a team environment.

• Supported financial control of engineering projects through budgeting , invoicing and account management.

Managed financial records and ensured compliance with accounting standards and regulations.